Evidence demonstrating role of microRNAs in the etiopathology of major depression

Journal of Chemical Neuroanatomy

Volumn 42, Issue 2, 2011, Pages 142-156

  Dwivedi, Yogesh ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Animal model of depression; Depression; Human postmortem brain; MicroRNA; Neurogenesis; Plasticity; Stress

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; GLUCOCORTICOID RECEPTOR; LIM KINASE 1; MESSENGER RNA; MICRORNA; NEUROPILIN 1; SYNAPTOJANIN; SYNAPTOTAGMIN I;

BIOGENESIS; EMOTIONAL DISORDER; GENE EXPRESSION REGULATION; HUMAN; INTRACELLULAR SIGNALING; MAJOR DEPRESSION; MENTAL STRESS; MOLECULAR PATHOLOGY; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; RNA TRANSLATION; SCHIZOPHRENIA;

ANIMALS; BRAIN CHEMISTRY; DEPRESSIVE DISORDER, MAJOR; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MICRORNAS; NEUROGENESIS; NEURONAL PLASTICITY;

EID: 80052100267     PISSN: 08910618     EISSN: 18736300     Source Type: Journal    
DOI: 10.1016/j.jchemneu.2011.04.002     Document Type: Review

References (186)

1. Aganova E.A., Uranova N.A. Morphometric analysis of synaptic contacts in the anterior limbic cortex in the endogenous psychoses. Neurosci. Behav. Physiol. 1992, 22:59-65.
2. Alonso M., Viollet C., Gabellec M.M., Meas-Yedid V., Olivo-Marin J.C., Lledo P.M. Olfactory discrimination learning increases the survival of adult-born neurons in the olfactory bulb. J. Neurosci. 2006, 26:10508-10513.
3. Ambros V. The functions of animal microRNAs. Nature 2004, 431:350-355.
4. Andreasen N.C. Linking mind and brain in the study of mental illnesses: a project for a scientific psychopathology. Science 1997, 275:1586-1593.
5. Ashraf S.I., McLoon A.L., Sclarsic S.M., Kunes S. Synaptic protein synthesis associated with memory is regulated by the RISC pathway in Drosophila. Cell 2006, 124:191-205.
6. Banerjee S., Neveu P., Kosik K.S. A coordinated local translational control point at the synapse involving relief from silencing and MOV10 degradation. Neuron 2009, 64:871-884.
7. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
8. Baudry A., Mouillet-Richard S., Schneider B., Launay J.M., Kellermann O. miR-16 targets the serotonin transporter: a new facet for adaptive responses to antidepressants. Science 2010, 329:1537-1541.
9. Bearden C.E., Glahn D.C., Monkul E.S., Barrett J., Najt P., Villarreal V., Soares J.C. Patterns of memory impairment in bipolar disorder and unipolar major depression. Psychiatry Res. 2006, 142:139-150.
10. Beveridge N.J., Gardiner E., Carroll A.P., Tooney P.A., Cairns M.J. Schizophrenia is associated with an increase in cortical microRNA biogenesis. Mol. Psychiatry 2010, 15:1176-1189.
11. Beveridge N.J., Tooney P.A., Carroll A.P., Gardiner E., Bowden N., Scott R.J., Tran N., Dedova I., Cairns M.J. Dysregulation of miRNA 181b in the temporal cortex in schizophrenia. Hum. Mol. Genet. 2008, 17:1156-1168.
12. Bracken C.P., Gregory P.A., Kolesnikoff N., Bert A.G., Wang J., Shannon M.F., Goodall G.J. A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. Cancer Res. 2008, 68:7846-7854.
13. Brockington A., Lewis C., Wharton S., Shaw P.J. Vascular endothelial growth factor and the nervous system. Neuropathol. Appl. Neurobiol. 2004, 30:427-446.
14. Brunoni A.R., Lopes M., Fregni F. A systematic review and meta-analysis of clinical studies on depression and BDNF levels: implications for the role of neuroplasticity in depression. Int. J. Neuropsychopharmacol. 2008, 11:1169-1180.
15. Bushati N., Cohen S.M. microRNA functions. Annu. Rev. Cell. Dev. Biol. 2007, 23:175-205.
16. Cao L., Jiao X., Zuzga D.S., Liu Y., Fong D.M., Young D. VEGF links hippocampal activity with neurogenesis, learning and memory. Nat. Genet. 2004, 36:827-835.
17. Castrén E., Rantamäki T. Neurotrophins in depression and antidepressant effects. Novartis Found. Symp. 2008, 289:43-52.
18. Caudy A.A., Myers M., Hannon G.J., Hammond S.M. Fragile X-related protein and VIG associate with the RNA interference machinery. Genes Dev. 2002, 16:2491-2496.
19. Chen B., Dowlatshahi D., MacQueen G.M., Wang J.F., Young L.T. Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol. Psychiatry 2001, 50:260-265.
20. Chen H., Pandey G.N., Dwivedi Y. Hippocampal cell proliferation regulation by repeated stress and antidepressants. Neuroreport 2006, 17:863-867.
21. Chen H., Wang N., Burmeister M., McInnis M.G. MicroRNA expression changes in lymphoblastoid cell lines in response to lithium treatment. Int. J. Neuropsychopharmacol. 2009, 2:1-7.
22. Cheng L.C., Pastrana E., Tavazoie M., Doetsch F. miR-124 regulates adult neurogenesis in the subventricular zone stem cell niche. Nat. Neurosci. 2009, 12:399-408.
23. Choi P.S., Zakhary L., Choi W.Y., Caron S., Alvarez-Saavedra E., Miska E.A., McManus M., Harfe B., Giraldez A.J., Horvitz H.R., Schier A.F., Dulac C. Members of the miRNA-200 family regulate olfactory neurogenesis. Neuron 2008, 57:41-55.
24. Christensen M., Schratt G.M. microRNA involvement in developmental and functional aspects of the nervous system and in neurological diseases. Neurosci. Lett. 2009, 466:55-62.
25. Cimmino A., Calin G.A., Fabbri M., Iorio M.V., Ferracin M., Shimizu M., Wojcik S.E., Aqeilan R.I., Zupo S., Dono M., Rassenti L., Alder H., Volinia S., Liu C.G., Kipps T.J., Negrini M., Croce C.M. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:13944-13949.
26. Conaco C., Otto S., Han J.J., Mandel G. Reciprocal actions of REST and a microRNA promote neuronal identity. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:2422-2427.
27. Cooper J.D., Skepper J.N., Berzaghi M.D., Lindholm D., Sofroniew M.V. Delayed death of septal cholinergic neurons after excitotoxic ablation of hippocampal neurons during early postnatal development in the rat. Exp. Neurol. 1996, 139:143-155.
28. Cotter D., Mackay D., Landau S., Kerwin R., Everall I. Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder. Arch. Gen. Psychiatry 2001, 58:545-553.
29. Croce C.M. Causes and consequences of microRNA dysregulation in cancer. Nat. Rev. Genet. 2009, 10:704-714.
30. de Kloet E.R., Fitzsimons C.P., Datson N.A., Meijer O.C., Vreugdenhil E. Glucocorticoid signaling and stress-related limbic susceptibility pathway: about receptors, transcription machinery and microRNA. Brain Res. 2009, 1293:129-141.
31. DeCarolis N.A., Eisch A.J. Hippocampal neurogenesis as a target for the treatment of mental illness: a critical evaluation. Neuropharmacology 2010, 58:884-893.
32. Dolan R.J., Bench C.J., Liddle P.F., Friston K.J., Frith C.D., Grasby P.M., Frackowiak R.S. Dorsolateral prefrontal cortex dysfunction in the major psychoses; symptom or disease specificity?. J. Neurol. Neurosurg. Psychiatry 1993, 56:1290-1294.
33. Drevets W.C., Ongür D., Price J.L. Reduced glucose metabolism in the subgenual prefrontal cortex in unipolar depression. Mol. Psychiatry 1998, 3:190-191.
34. Duman R.S. Pathophysiology of depression: the concept of synaptic plasticity. Eur. Psychiatry 2002, 3:306-310.
35. Duman R.S., Malberg J., Nakagawa S., D'Sa C. Neuronal plasticity and survival in mood disorders. Biol. Psychiatry 2000, 48:732-739.
36. Dunham J.S., Deakin J.F., Miyajima F., Payton A., Toro C.T. Expression of hippocampal brain-derived neurotrophic factor and its receptors in Stanley consortium brains. J. Psychiatr. Res. 2009, 43:1175-1184.
37. Dupret D., Revest J.M., Koehl M., Ichas F., De Giorgi F., Costet P., Abrous D.N., Piazza P.V. Spatial relational memory requires hippocampal adult neurogenesis. PLoS One 2008, 3:e1959.
38. Dwivedi Y., Mondal A.C., Rizavi H.S., Shukla P.K., Pandey G.N. Single and repeated stress-induced modulation of phospholipase C catalytic activity and expression: role in LH behavior. Neuropsychopharmacology 2005, 30:473-483.
39. Dwivedi Y., Pandey G.N. Adenylyl cyclase-cyclicAMP signaling in mood disorders: role of the crucial phosphorylating enzyme protein kinase A. Neuropsychiatr. Dis. Treat. 2008, 4:161-176.
40. Dwivedi Y., Mondal A.C., Payappagoudar G.V., Rizavi H.S. Differential regulation of serotonin (5HT)2A receptor mRNA and protein levels after single and repeated stress in rat brain: role in learned helplessness behavior. Neuropharmacology 2005, 48:204-214.
41. Dwivedi Y., Mondal A.C., Rizavi H.S., Conley R.R. Suicide brain is associated with decreased expression of neurotrophins. Biol. Psychiatry 2005, 58:315-324.
42. Dwivedi Y., Mondal A.C., Rizavi H.S., Faludi G., Palkovits M., Sarosi A., Conley R.R., Pandey G.N. Differential and brain region-specific regulation of Rap-1 and Epac in depressed suicide victims. Arch. Gen. Psychiatry 2006, 63:639-648.
43. Dwivedi Y., Mondal A.C., Shukla P.K., Rizavi H.S., Lyons J. Altered protein kinase a in brain of learned helpless rats: effects of acute and repeated stress. Biol. Psychiatry 2004, 56:30-40.
44. Dwivedi Y., Rao J.S., Rizavi H.S., Kotowski J., Conley R.R., Roberts R.C., Tamminga C.A., Pandey G.N. Abnormal expression and functional characteristics of cyclic adenosine monophosphate response element binding protein in postmortem brain of suicide subjects. Arch. Gen. Psychiatry 2003, 60:273-282.
45. Dwivedi Y., Rizavi H., Zhang H., Mondal A.C., Roberts R.C., Conley R.R., Pandey G.N. Neurotrophin receptor activation and expression in human postmortem brain: effect of suicide. Biol. Psychiatry 2009, 65:319-328.
46. Dwivedi Y., Rizavi H.S., Conley R.R., Pandey G.N. ERK MAP kinase signaling in post-mortem brain of suicide subjects: differential regulation of upstream Raf kinases Raf-1 and B-Raf. Mol. Psychiatry 2006, 11:86-98.
47. Dwivedi Y., Rizavi H.S., Conley R.R., Roberts R.C., Tamminga C.A., Pandey G.N. Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. Arch. Gen. Psychiatry 2003, 60:804-815.
48. Dwivedi Y., Rizavi H.S., Roberts R.C., Conley R.C., Tamminga C.A., Pandey G.N. Reduced activation and expression of ERK1/2 MAP kinase in the postmortem brain of depressed suicide subjects. J. Neurochem. 2001, 77:916-928.
49. Dwivedi Y., Rizavi H.S., Teppen T., Sasaki N., Chen H., Zhang H., Roberts R.C., Conley R.R., Pandey G.N. Aberrant extracellular signal-regulated kinase (ERK) 5 signaling in hippocampus of suicide subjects. Neuropsychopharmacology 2007, 32:2338-23350.
50. Dwivedi Y., Rizavi H.S., Zhang H., Roberts R.C., Conley R.R., Pandey G.N. Aberrant extracellular signal-regulated kinase (ERK)1/2 signaling in suicide brain: role of ERK kinase 1 (MEK1). Int. J. Neuropsychopharmacol. 2009, 12:1337-1354.
51. Dwivedi Y. Brain-derived neurotrophic factor: role in depression and suicide. Neuropsychiatr. Dis. Treat. 2009, 5:433-449.
52. Fanous S., Hammer R.P., Nikulina E.M. Short- and long-term effects of intermittent social defeat stress on brain-derived neurotrophic factor expression in mesocorticolimbic brain regions. Neuroscience 2010, 167:598-607.
53. Fénelon K., Mukai J., Xu B., Hsu P.K., Drew L.J., Karayiorgou M., Fischbach G.D., Macdermott A.B., Gogos J.A. Deficiency of Dgcr8, a gene disrupted by the 22q11.2 microdeletion, results in altered short-term plasticity in the prefrontal cortex. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:4447-4452.
54. Feng J., Sun G., Yan J., Noltner K., Li W., Buzin C.H., Longmate J., Heston L.L., Rossi J., Sommer S.S. Evidence for X-chromosomal schizophrenia associated with microRNA alterations. PLoS One 2009, 1:e6121.
55. Ferrara N., Gerber H.P., LeCouter J. The biology of VEGF and its receptors. Nat. Med. 2003, 9:669-676.
56. Finkel T., Deng C.X., Mostoslavsky R. Recent progress in the biology and physiology of sirtuins. Nature 2009, 460:587-591.
57. Fiore R., Siegel G., Schratt G. MicroRNA function in neuronal development, plasticity and disease. Biochim. Biophys. Acta 2008, 1779:471-478.
58. Fossati P., Radtchenko A., Boyer P. Neuroplasticity: from MRI to depressive symptoms. Eur. Neuropsychopharmacol. 2004, 14:S503-S510.
59. Frodl T., Schaub A., Banac S., Charypar M., Jäger M., Kümmler P., Bottlender R., Zetzsche T., Born C., Leinsinger G., Reiser M., Möller H.J., Meisenzahl E.M. Reduced hippocampal volume correlates with executive dysfunctioning in major depression. J. Psychiatry Neurosci. 2006, 31:316-323.
60. Gao F.B. Posttranscriptional control of neuronal development by microRNA networks. Trends Neurosci. 2008, 31:20-26.
61. Gao J., Wang W.Y., Mao Y.W., Gräff J., Guan J.S., Pan L., Mak G., Kim D., Su S.C., Tsai L.H. A novel pathway regulates memory and plasticity via SIRT1 and miR-134. Nature 2010, 466:1105-1109.
62. Gass P., Riva M.A. CREB, neurogenesis and depression. Bioessays 2007, 29:957-961.
63. Góra-Kupilas K., Jośko J. The neuroprotective function of vascular endothelial growth factor (VEGF). Folia Neuropathol. 2005, 43:31-39.
64. Gourley S.L., Wu F.J., Taylor J.R. Corticosterone regulates pERK1/2 map kinase in a chronic depression model. Ann. N. Y. Acad. Sci. 2008, 1148:509-514.
65. Guo A.Y., Sun J., Jia P., Zhao Z. A novel microRNA and transcription factor mediated regulatory network in schizophrenia. BMC Syst. Biol. 2010, 4:10-14.
66. Hajsza T., MacLusky N.J., Leranth C. Short-term treatment with the antidepressant fluoxetine triggers pyramidal dendritic spine synapse formation in rat hippocampus. Eur. J. Neurosci. 2005, 21:1299-1303.
67. Honer W.G. Assessing the machinery of mind: synapses in neuropsychiatric disorders. J. Psychiatry Neurosci. 1999, 24:116-121.
68. Horan W.P., Pogge D.L., Borgaro S.R., Stokes J.M., Harvey P.D. Learning and memory in adolescent psychiatric inpatients with major depression: a normative study of the California Verbal Learning Test. Arch. Clin. Neuropsychol. 1997, 12:575-584.
69. Howland J.G., Wang Y.T. Synaptic plasticity in learning and memory: stress effects in the hippocampus. Prog. Brain Res. 2008, 169:145-158.
70. Hüttenhofer A., Schattner P., Polacek N. Non-coding RNAs: hope or hype?. Trends Genet. 2005, 21:289-297.
71. Hyman S.E., Nestler E.J. The Molecular Foundations of Psychiatry 1993, American Psychiatric Press, Washington, DC.
72. Iga J., Ueno S., Yamauchi K., Numata S., Tayoshi-Shibuya S., Kinouchi S. Gene expression and association analysis of vascular endothelial growth factor in major depressive disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2007, 31:658-663.
73. Impey S., Davare M., Lasiek A., Fortin D., Ando H., Varlamova O., Obrietan K., Soderling T.R., Goodman R.H., Wayman G.A. An activity-induced microRNA controls dendritic spine formation by regulating Rac1-PAK signaling. Mol. Cell Neurosci. 2010, 43:146-156.
74. Ishizuka A., Siomi M.C., Siomi H. A Drosophila fragile X protein interacts with components of RNAi and ribosomal proteins. Genes Dev. 2002, 16:2497-2508.
75. Jensen K.P., Covault J., Conner T.S., Tennen H., Kranzler H.R., Furneaux H.M. A common polymorphism in serotonin receptor 1B mRNA moderates regulation by miR-96 and associates with aggressive human behaviors. Mol. Psychiatry 2009, 14:381-389.
76. Jin P., Zarnescu D.C., Ceman S., Nakamoto M., Mowrey J., Jongens T.A., Nelson D.L., Moses K., Warren S.T. Biochemical and genetic interaction between the fragile X mental retardation protein and the microRNA pathway. Nat. Neurosci. 2004, 7:113-117.
77. Kapsimali M., Kloosterman W.P., de Bruijn E., Rosa F., Plasterk R.H., Wilson S.W. MicroRNAs show a wide diversity of expression profiles in the developing and mature central nervous system. Genome Biol. 2007, 8:R173.
78. Karege F., Vaudan G., Schwald M., Perroud N., La Harpe R. Neurotrophin levels in postmortem brains of suicide victims and the effects of antemortem diagnosis and psychotropic drugs. Brain. Res. Mol. Brain. Res. 2005, 136:29-37.
79. Kawashima H., Numakawa T., Kumamaru E., Adachi N., Mizuno H., Ninomiya M., Kunugi H., Hashido K. Glucocorticoid attenuates brain-derived neurotrophic factor-dependent upregulation of glutamate receptors via the suppression of microRNA-132 expression. Neuroscience 2010, 165:1301-1311.
80. Kessler R.C., McGonagle K.A., Zhao S., Nelson C.B., Hughes M., Eshleman S., Wittchen H.U., Kendler K.S. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch. Gen. Psychiatry 1994, 51:8-19.
81. Kim A.H., Reimers M., Maher B., Williamson V., McMichael O., McClay J.L., van den Oord E.J., Riley B.P., Kendler K.S., Vladimirov V.I. MicroRNA expression profiling in the prefrontal cortex of individuals affected with schizophrenia and bipolar disorders. Schizophr. Res. 2010, 124:183-191.
82. Kim H.W., Rapoport S.I., Rao J.S. Altered expression of apoptotic factors and synaptic markers in postmortem brain from bipolar disorder patients. Neurobiol. Dis. 2010, 37:596-603.
83. Konopka W., Kiryk A., Novak M., Herwerth M., Parkitna J.R., Wawrzyniak M., Kowarsch A., Michaluk P., Dzwonek J., Arnsperger T., Wilczynski G., Merkenschlager M., Theis F.J., Köhr G., Kaczmarek L., Schütz G. MicroRNA loss enhances learning and memory in mice. J. Neurosci. 2010, 30:14835-14842.
84. Kosik K.S. The neuronal microRNA system. Nat. Rev. Neurosci. 2006, 7:911-920.
85. Kozisek M.E., Middlemas D., Bylund D.B. Brain-derived neurotrophic factor and its receptor tropomyosin-related kinase B in the mechanism of action of antidepressant therapies. Pharmacol. Ther. 2008, 117:30-51.
86. Kumamaru E., Numakawa T., Adachi N., Yagasaki Y., Izumi A., Niyaz M., Kudo M., Kunugi H. Glucocorticoid prevents brain-derived neurotrophic factor-mediated maturation of synaptic function in developing hippocampal neurons through reduction in the activity of mitogen-activated protein kinase. Mol. Endocrinol. 2008, 22:546-558.
87. Kwak P.B., Iwasaki S., Tomari Y. The microRNA pathway and cancer. Cancer Sci. 2010, 101:2309-2315.
88. Landgraf P., Rusu M., Sheridan R., Sewer A., Iovino N., Aravin A., Pfeffer S., Rice A., Kamphorst A.O., Landthaler M., Lin C., Socci N.D., Hermida L., Fulci V., Chiaretti S., Foà R., Schliwka J., Fuchs U., Novosel A., Müller R.U., Schermer B., Bissels U., Inman J., Phan Q., Chien M., Weir D.B., Choksi R., De Vita G., Frezzetti D., Trompeter H.I., Hornung V., Teng G., Hartmann G., Palkovits M., Di Lauro R., Wernet P., Macino G., Rogler C.E., Nagle J.W., Ju J., Papavasiliou F.N., Benzing T., Lichter P., Tam W., Brownstein M.J., Bosio A., Borkhardt A., Russo J.J., Sander C., Zavolan M., Tuschl T. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 2007, 129:1401-1414.
89. Lazarov O., Mattson M.P., Peterson D.A., Pimplikar S.W., van Praag H. When neurogenesis encounters aging and disease. Trends Neurosci. 2010, 33:569-579.
90. Li L.C., Okino S.T., Zhao H., Pookot D., Place R.F., Urakami S., Enokida H., Dahiya R. Small dsRNAs induce transcriptional activation in human cells. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:17337-17342.
91. Liu C., Zhao X. MicroRNAs in adult and embryonic neurogenesis. Neuromol. Med. 2009, 11:141-152.
92. Liu R.T., Alloy L.B. Stress generation in depression: a systematic review of the empirical literature and recommendations for future study. Clin. Psychol. Rev. 2010, 30:582-593.
93. Lucassen P.J., Meerlo P., Naylor A.S., van Dam A.M., Dayer A.G., Fuchs E., Oomen C.A., Czéh B. Regulation of adult neurogenesis by stress, sleep disruption, exercise and inflammation: implications for depression and antidepressant action. Eur. Neuropsychopharmacol. 2010, 20:1-17.
94. Lugli G., Larson J., Martone M.E., Jones Y., Smalheiser N.R. Dicer and eIF2c are enriched at postsynaptic densities in adult mouse brain and are modified by neuronal activity in a calpain-dependent manner. J. Neurochem. 2005, 94:896-905.
95. Lugli G., Torvik V.I., Larson J., Smalheiser N.R. Expression of microRNAs and their precursors in synaptic fractions of adult mouse forebrain. J. Neurochem. 2008, 106:650-661.
96. Machado-Vieira R., Salvadore G., DiazGranados N., Ibrahim L., Latov D., Wheeler-Castillo C., Baumann J., Henter I.D., Zarate C.A. New therapeutic targets for mood disorders. Sci. World J. 2010, 10:713-726.
97. Malberg J.E., Monteggia L.M. VGF, a new player in antidepressant action?. Sci. Signal. 2008, 1:19.
98. Manji H.K., Quiroz J.A., Sporn J., Payne J.L., Denicoff K.A., Gray N., Zarate C.A., Charney D.S. Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression. Biol. Psychiatry 1998, 53:707-742.
99. Mann J.J. The neurobiology of suicide. Nat. Med. 1998, 4:25-30.
100. Marmol F. Lithium: bipolar disorder and neurodegenerative diseases. Possible cellular mechanisms of the therapeutic effects of lithium. Prog. Neuropsychopharmacol. Biol. Psychiatry 2008, 232:1761-1771.
101. Matigian N., Windus L., Smith H., Filippich C., Pantelis C., McGrath J., Mowry B., Hayward N. Expression profiling in monozygotic twins discordant for bipolar disorder reveals dysregulation of the WNT signalling pathway. Mol. Psychiatry 2007, 12:815-825.
102. McAllister A.K. Neurotrophins and neuronal differentiation in the central nervous system. Cell. Mol. Life Sci. 2001, 58:1054-1060.
103. McAllister A.K., Katz L.C., Lo D.C. Neurotrophins and synaptic plasticity. Annu. Rev. Neurosci. 1999, 22:295-318.
104. McCloskey D.P., Croll S.D., Scharfman H.E. Depression of synaptic transmission by vascular endothelial growth factor in adult rat hippocampus and evidence for increased efficacy after chronic seizures. J. Neurosci. 2005, 25:8889-8897.
105. McEwen B.S. Effects of adverse experiences for brain structure and function. Biol. Psychiatry 2000, 48:713-714.
106. Meerson A., Cacheaux L., Goosens K.A., Sapolsky R.M., Soreq H., Kaufer D. Changes in brain MicroRNAs contribute to cholinergic stress reactions. J. Mol. Neurosci. 2010, 40:47-55.
107. Mellios N., Huang H.S., Grigorenko A., Rogaev E., Akbarian S. A set of differentially expressed miRNAs, including miR-30a-5p, act as post-transcriptional inhibitors of BDNF in prefrontal cortex. Hum. Mol. Genet. 2008, 17:3030-3042.
108. Michalak P. RNA world-the dark matter of evolutionary genomics. J. Evol. Biol. 2006, 19:1768-1774.
109. Miguel-Hidalgo J., Rajkowska G. Morphological brain changes in depression. Can antidepressants reverse them?. CNS Drugs 2002, 16:361-372.
110. Millan M.J. MicroRNA in the regulation and expression of serotonergic transmission in the brain and other tissues. Curr. Opin. Pharmacol. 2011, 11:11-22.
111. miRBase, 2010. Available from the web address:. http://www.mirbase.org/.
112. Miska E.A., Alvarez-Saavedra E., Townsend M., Yoshii A., Sestan N., Rakic P., Constantine-Paton M., Horvitz H.R. Microarray analysis of microRNA expression in the developing mammalian brain. Genome Biol. 2004, 5:R68.
113. Nakahata Y., Kaluzova M., Grimaldi B., Sahar S., Hirayama J., Chen D., Guarente L.P., Sassone-Corsi P. The NAD+-dependent deacetylase SIRT1 modulates CLOCK-mediated chromatin remodeling and circadian control. Cell 2008, 134:329-340.
114. Numakawa T., Kumamaru E., Adachi N., Yagasaki Y., Izumi A., Kunugi H. Glucocorticoid receptor interaction with TrkB promotes BDNF-triggered PLC-gamma signaling for glutamate release via a glutamate transporter. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:647-652.
115. Ongur D., Drevets W.C., Price J.L. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:13290-13295.
116. Otsuki K., Uchida S., Watanuki T., Wakabayashi Y., Fujimoto M., Matsubara T., Funato H., Watanabe Y. Altered expression of neurotrophic factors in patients with major depression. J. Psychiatr. Res. 2008, 42:1145-1153.
117. Otto S.J., McCorkle S.R., Hover J., Conaco C., Han J.J., Impey S., Yochum G.S., Dunn J.J., Goodman R.H., Mandel G. A new binding motif for the transcriptional repressor REST uncovers large gene networks devoted to neuronal functions. J. Neurosci. 2007, 27:6729-6739.
118. Ovtscharoff W., Braun K. Maternal separation and social isolation modulate the postnatal development of synaptic composition in the infralimbic cortex of Octodon degus. Neuroscience 2001, 104:33-40.
119. Palmer T.D., Willhoite A.R., Gage F.H. Vascular niche for adult hippocampal neurogenesis. J. Comp. Neurol. 2000, 425:479-494.
120. Pandey G.N., Dwivedi Y., Pandey S.C., Conley R.R., Roberts R.C., Tamminga C.A. Protein kinase C in the postmortem brain of teenage suicide victims. Neurosci. Lett. 1997, 228:111-114.
121. Pariante C.M., Miller A.H. Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment. Biol. Psychiatry 2001, 49:391-404.
122. Pascual R., Zamora-León P., Catalán-Ahumada M., Valero-Cabré A. Early social isolation decreases the expression of calbindin D-28k and dendritic branching in the medial prefrontal cortex of the rat. Int. J. Neurosci. 2007, 117:465-476.
123. Place R.F., Li L.C., Pookot D., Noonan E.J., Dahiya R. MicroRNA-373 induces expression of genes with complementary promoter sequences. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:1608-1613.
124. Presutti C., Rosati J., Vincenti S., Nasi S. Non coding RNA and brain. BMC Neurosci. Suppl. 2006, 1:S5.
125. Qi X., Lin W., Li J., Li H., Wang W., Wang D., Sun M. Fluoxetine increases the activity of the ERK-CREB signal system and alleviates the depressive-like behavior in rats exposed to chronic forced swim stress. Neurobiol. Dis. 2008, 31:278-285.
126. Qurashi A., Chang S., Peng J. Role of microRNA pathway in mental retardation. Sci. World J. 2007, 7:146-154.
127. Qurashi A., Jin P. Small RNA-mediated gene regulation in neurodevelopmental disorders. Curr. Psychiatry Rep. 2010, 12:154-161.
128. Qureshi, I.A., Mehler, M.F., in press. Non-coding RNA networks underlying cognitive disorders across the lifespan. Trends Mol. Med., (PMID 21411369).
129. Raab S., Plate K.H. Different networks, common growth factors: shared growth factors and receptors of the vascular and the nervous system. Acta Neuropathol. 2007, 113:607-626.
130. Rajasethupathy P., Fiumara F., Sheridan R., Betel D., Puthanveettil S.V., Russo J.J., Sander C., Tuschl T., Kandel E. Characterization of small RNAs in Aplysia reveals a role for miR-124 in constraining synaptic plasticity through CREB. Neuron 2009, 63:803-817.
131. Rajkowska G. Hisopathology of the prefrontal cortex in major depression: what does it tell us about dysfunctional monoaminergic circuits?. Prog. Brain Res. 2000, 126:397-412.
132. Rajkowska G., Miguel-Hidalgo J.J. Gliogenesis and glial pathology in depression. CNS Neurol. Disord. Drug Targets 2007, 6:219-233.
133. Rigau V., Morin M., Rousset M.C., de Bock F., Lebrun A., Coubes P. Angiogenesis is associated with blood-brain barrier permeability in temporal lobe epilepsy. Brain 2007, 130:1942-1956.
134. Rinaldi A., Vincenti S., De Vito F., Bozzoni I., Oliverio A., Presutti C., Fragapane P., Mele A. Stress induces region specific alterations in microRNAs expression in mice. Behav. Brain Res. 2010, 208:265-269.
135. Rong H., Liu T.B., Yang K.J., Yang H.C., Wu D.H., Liao C.P., Hong F., Yang H.Z., Wan F., Ye X.Y., Xu D., Zhang X., Chao C.A., Shen Q.J. MicroRNA-134 plasma levels before and after treatment for bipolar mania. J. Psychiatr. Res. 2011, 45:92-95.
136. Rosoklija G., Toomayan G., Ellis S.P., Keilp J., Mann J.J., Latov N., Hays A.P., Dwork A.J. Structural abnormalities of subicular dendrites in subjects with schizophrenia and mood disorders: preliminary findings. Arch. Gen. Psychiatry 2000, 57:349-356.
137. Ross J.S., Carlson J.A., Brock G. miRNA: the new gene silencer. Am. J. Clin. Pathol. 2007, 128:830-836.
138. Sackeim H.A. Functional brain circuits in major depression and remission. Arch. Gen. Psychiatry 2001, 58:649-650.
139. Sala M., Perez J., Soloff P., Ucelli di Nemi S., Caverzasi E., Soares J.C., Brambilla P. Stress and hippocampal abnormalities in psychiatric disorders. Eur. Neuropsychopharmacol. 2004, 14:393-405.
140. Santarelli D.M., Beveridge N.J., Tooney P.A., Cairns M.J. Upregulation of dicer and microRNA expression in the dorsolateral prefrontal cortex Brodmann area 46 in schizophrenia. Biol. Psychiatry 2011, 69:180-187.
141. Saus E., Brunet A., Armengol L., Alonso P., Crespo J.M., Fernández-Aranda F., Guitart M., Martín-Santos R., Menchón J.M., Navinés R., Soria V., Torrens M., Urretavizcaya M., Vallès V., Gratacòs M., Estivill X. Comprehensive copy number variant (CNV) analysis of neuronal pathways genes in psychiatric disorders identifies rare variants within patients. J. Psychiatr. Res. 2010, 44:971-978.
142. Schratt G.M., Nigh E.A., Chen W.G., Hu L., Greenberg M.E. BDNF regulates the translation of a select group of mRNAs by a mammalian target of rapamycin-phosphatidylinositol 3-kinase-dependent pathway during neuronal development. J. Neurosci. 2004, 24:7366-7377.
143. Schratt G.M., Tuebing F., Nigh E.A., Kane C.G., Sabatini M.E., Kiebler M., Greenberg M.E. A brain-specific microRNA regulates dendritic spine development. Nature 2006, 439:283-289.
144. Seligman M.E., Maier S. Failure to escape traumatic shock. J. Exp. Psychol. 1967, 74:1-9.
145. Sempere L.F., Freemantle S., Pitha-Rowe I., Moss E., Dmitrovsky E., Ambros V. Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biol. 2004, 5:R13.
146. Sethupathy P., Collins F.S. MicroRNA target site polymorphisms and human disease. Trends Genet. 2008, 24:489-497.
147. Sheline Y.I. 3D MRI studies of neuroanatomic changes in unipolar major depression: the role of stress and medical comorbidity. Biol. Psychiatry 2000, 48:791-800.
148. Shi S.S., Shao S.H., Yuan B.P., Pan F., Li Z.L. Acute stress and chronic stress change brain-derived neurotrophic factor (BDNF) and tyrosine kinase-coupled receptor (TrkB) expression in both young and aged rat hippocampus. Yonsei Med. J. 2010, 51:661-671.
149. Siegel G., Obernosterer G., Fiore R., Oehmen M., Bicker S., Christensen M., Khudayberdiev S., Leuschner P.F., Busch C.J., Kane C., Hübel K., Dekker F., Hedberg C., Rengarajan B., Drepper C., Waldmann H., Kauppinen S., Greenberg M.E., Draguhn A., Rehmsmeier M., Martinez J., Schratt G.M. A functional screen implicates microRNA-138-dependent regulation of the depalmitoylation enzyme APT1 in dendritic spine morphogenesis. Nat. Cell Biol. 2009, 11:705-716.
150. Smalheiser, N.R., Lugli, G., Rizavi, H.S., Zhang, H., Torvik, V.I., Pandey G.N., Davis, J.M., Dwivedi, Y., in press. MicroRNA expression in rat brain exposed to repeated inescapable shock: differential alterations in learned helplessness vs. non-learned helplessness. Int. J. Neuropsychopharmacol., (PMID 21275079).
151. Smirnova L., Gräfe A., Seiler A., Schumacher S., Nitsch R., Wulczyn F.G. Regulation of miRNA expression during neural cell specification. Eur. J. Neurosci. 2005, 21:1469-1477.
152. Smith M.A., Makino S., Kvetnansky R., Post R.M. Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J. Neurosci. 1995, 15:1768-1777.
153. Sofroniew M.V., Galletly N.P., Isacson O., Svendsen C.N. Survival of adult basal cholinergic neurons after loss of target neurons. Science 1990, 247:338-342.
154. Soloff P.H., Lynch K.G., Kelly T.M., Malone K.M., Mann J.J. Characteristics of suicide attempts of patients with major depressive episode and borderline personality disorder: a comparative study. Am. J. Psychiatry 2000, 157:601-608.
155. Stevenson C.W., Marsden C.A., Mason R. Early life stress causes FG-7142-induced corticolimbic dysfunction in adulthood. Brain Res. 2008, 1193:43-50.
156. Szulwach K.E., Li X., Smrt R.D., Li Y., Luo Y., Lin L., Santistevan N.J., Li W., Zhao X., Jin P. Cross talk between microRNA and epigenetic regulation in adult neurogenesis. J. Cell Biol. 2010, 189:127-141.
157. Taft R.J., Pang K.C., Mercer T.R., Dinger M., Mattick J.S. Non-coding RNAs: regulators of disease. J. Pathol. 2010, 220:126-139.
158. Tanis K.Q., Newton S.S., Duman R.S. Targeting neurotrophic/growth factor expression and signaling for antidepressant drug development. CNS Neurol. Disord. Drug Targets 2007, 6:151-160.
159. Thoenen H. Neurotrophins and activity-dependent plasticity. Prog. Brain Res. 2000, 128:183-191.
160. Todorovic C., Sherrin T., Pitts M., Hippel C., Rayner M., Spiess J. Suppression of the MEK/ERK signaling pathway reverses depression-like behaviors of CRF2-deficient mice. Neuropsychopharmacology 2009, 34:1416-1426.
161. Toni N., Buchs P.A., Nikonenko I., Bron C.R., Muller D. LTP promotes formation of multiple spine synapses between a single axon terminal and a dendrite. Nature 1999, 402:421-425.
162. Tsang J., Zhu J., van Oudenaarden A. MicroRNA-mediated feedback and feedforward loops are recurrent network motifs in mammals. Mol. Cell 2007, 26:753-767.
163. Turner J.D., Alt S.R., Cao L., Vernocchi S., Trifonova S., Battello N., Muller C.P. Transcriptional control of the glucocorticoid receptor: CpG islands, epigenetics and more. Biochem. Pharmacol. 2010, 80:1860-6188.
164. Uchida S., Hara K., Kobayashi A., Funato H., Hobara T., Otsuki K., Yamagata H., McEwen B.S., Watanabe Y. Early life stress enhances behavioral vulnerability to stress through the activation of REST4-mediated gene transcription in the medial prefrontal cortex of rodents. J. Neurosci. 2010, 30:15007-15018.
165. Uchida S., Nishida A., Hara K., Kamemoto T., Suetsugi M., Fujimoto M., Watanuki T., Wakabayashi Y., Otsuki K., McEwen B.S., Watanabe Y. Characterization of the vulnerability to repeated stress in Fischer 344 rats: possible involvement of microRNA-mediated down-regulation of the glucocorticoid receptor. Eur. J. Neurosci. 2008, 27:2250-2261.
166. Vanderklish P.W., Edelman G.M. Differential translation and fragile X syndrome. Genes Brain. Behav. 2005, 4:360-384.
167. Vangompel M.J., Sametsky E.A., Clark M.F., Savage J.C., Disterhoft J.F., Kohtz J.D., Bond A.M. Balanced gene regulation by an embryonic brain ncRNA is critical for adult hippocampal GABA circuitry. Nat. Neurosci. 2009, 12:1020-1027.
168. Varol N., Konac E., Gurocak O.S., Sozen S. The realm of microRNAs in cancers. Mol. Biol. Rep. 2011, 38:1079-1089.
169. Vasudevan S., Tong Y., Steitz J.A. Switching from repression to activation: microRNAs can up-regulate translation. Science 2007, 318:1931-1934.
170. Verdel A., Vavasseur A., Le Gorrec M., Touat-Todeschini L. Common themes in siRNA-mediated epigenetic silencing pathways. Int. J. Dev. Biol. 2009, 53:245-257.
171. Vo N., Klein M.E., Varlamova O., Keller D.M., Yamamoto T., Goodman R.H., Impey S. A cAMP-response element binding protein-induced microRNA regulates neuronal morphogenesis. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:16426-16431.
172. Vreugdenhil E., Berezikov E. Fine-tuning the brain: MicroRNAs. Front. Neuroendocrinol. 2009, 31:128-133.
173. Vreugdenhil E., Verissimo C.S., Mariman R., Kamphorst J.T., Barbosa J.S., Zweers T., Champagne D.L., Schouten T., Meijer O.C., de Kloet E.R., Fitzsimons C.P. MicroRNA 18 and 124a down-regulate the glucocorticoid receptor: implications for glucocorticoid responsiveness in the brain. Endocrinology 2009, 150:2220-2228.
174. Wang V., Wu W. MicroRNA-based therapeutics for cancer. BioDrugs 2010, 23:15-23.
175. Wasserman D., Wasserman J., Sokolowski M. Genetics of HPA-axis, depression and suicidality. Eur. Psychiatry 2010, 25:278-280.
176. Wayman G.A., Davare M., Ando H., Fortin D., Varlamova O., Cheng H.Y., Marks D., Obrietan K., Soderling T.R., Goodman R.H., Impey S. An activity-regulated microRNA controls dendritic plasticity by down-regulating p250GAP. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:9093-9098.
177. Witke W. The role of profilin complexes in cell motility and other cellular processes. Trends Cell Biol. 2004, 14:461-469.
178. Wu J., Xie X. Comparative sequence analysis reveals an intricate network among REST, CREB and miRNA in mediating neuronal gene expression. Genome Biol. 2006, 7:R85.
179. Xu Y., Liu H., Li F., Sun N., Ren Y., Liu Z., Cao X., Wang Y., Liu P., Zhang K. A polymorphism in the microRNA-30e precursor associated with major depressive disorder risk and P300 waveform. J. Affect. Disord. 2010, 127:332-336.
180. Yagasaki Y., Numakawa T., Kumamaru E., Hayashi T., Su T.P., Kunugi H. Chronic antidepressants potentiate via sigma-1 receptors the brain-derived neurotrophic factor-induced signaling for glutamate release. J. Biol. Chem. 2006, 281:12941-21299.
181. Yamamoto K.K., Gonzalez G.A., Biggs W.H., Montminy M.R. Phosphorylation-induced binding and transcriptional efficacy of nuclear factor CREB. Nature 1988, 334:494-498.
182. Yendamuri S., Calin G.A. The role of microRNA in human leukemia: a review. Leukemia 2009, 23:1257-1263.
183. Yuan P., Zhou R., Wang Y., Li X., Li J., Chen G., Guitart X., Manji H.K. Altered levels of extracellular signal-regulated kinase signaling proteins in postmortem frontal cortex of individuals with mood disorders and schizophrenia. J. Affect. Disord. 2010, 124:164-169.
184. Zhou R., Yuan P., Wang Y., Hunsberger J.G., Elkahloun A., Wei Y., Damschroder-Williams P., Du J., Chen G., Manji H.K. Evidence for selective microRNAs and their effectors as common long-term targets for the actions of mood stabilizers. Neuropsychopharmacology 2009, 34:1395-1405.
185. Zhou Y., Ferguson J., Chang J.T., Kluger Y. Inter- and intra-combinatorial regulation by transcription factors and microRNAs. BMC Genom. 2007, 8(October):396.
186. Zhu Y., Kalbfleisch T., Brennan M.D., Li Y. A MicroRNA gene is hosted in an intron of a schizophrenia-susceptibility gene. Schizophr. Res. 2009, 109:86-89.